drugset
drugset / Trial / NCT03495739

Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male Volunteers

NCT03495739 ↗

Phase 1 Unknown 64 enrolled Huons Co., Ltd.
RandomizedCrossoverSingle-blindTreatment

Summary

A randomized, open-label, single-dosing, 2x2 crossover study, the safety and pharmacokinetics of RDG-17012 with Pradaxa® in healthy male volunteers

Timeline

Start
2018-02-01
Primary completion
2018-06-01
Completion
2018-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dabigatran etexilate Unknown 150 mg Oral
Subject RDG-17012 Unknown 150 mg —

Indications

No indication recorded.